Sector consensus Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Real-time Estimate
Tradegate
11:09:40 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 58.80 EUR | +0.60% |
|
+1.83% | -7.66% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,325.39 | +15.01% | 29 | ||||||
| 277.91 | +2.85% | 22 | ||||||
| 278.61 | +5.52% | 28 | ||||||
| 375.34 | +3.92% | 19 | ||||||
| 152.93 | +8.66% | 22 | ||||||
| 210.54 | +26.88% | 23 | ||||||
| 387.69 | +2.08% | 29 | ||||||
| 310.17 | +11.03% | 23 | ||||||
| 158.15 | +4.81% | 27 | ||||||
| 28.88 | +4.47% | 26 | ||||||
| 569.19 | +10.23% | 27 | ||||||
| 66.71 | +6.16% | 24 | ||||||
| 94.06 | +24.98% | 24 | ||||||
| 21.71 | +14.26% | 21 | ||||||
| 9,323.33 | +39.49% | 15 | ||||||
| 6,622.06 | +11.37% | 16 | ||||||
| 58.22 | +18.72% | 18 | ||||||
| 71.35 | +65.06% | 17 | ||||||
| Average | 1,129.57 | +15.31% | 23 | ||||||
| Weighted average by Cap. | 726.27 | +10.78% | 25 |
Select your edition
All financial news and data tailored to specific country editions
